SAB Biotherapeutics Price Chart
SAB Biotherapeutics Volume Chart
SAB Biotherapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $3.53 |
|---|---|
| Close | $3.53 |
| Low | $3.53 |
| Low Change | 0.00 (0.00%) |
| High | $3.53 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 420 |
| Dollar Volume | $1.48K |
Regular Trading Hours Yesterday
+0.07(+1.87%)
| Open | $3.47 |
|---|---|
| Close | $3.54 |
| Low | $3.43 |
| Low Change | -0.04 (-1.15%) |
| High | $3.56 |
| High Change | +0.09 (+2.59%) |
| Range | $0.13 |
| Volume | 214.421K |
| Dollar Volume | $757.98K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $3.41 |
|---|---|
| Close | $3.41 |
| Low | $3.41 |
| Low Change | 0.00 (0.00%) |
| High | $3.41 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 109 |
| Dollar Volume | $371.69 |
SAB Biotherapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $3.67 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.78 |
| 20 Day Moving Average (SMA20) | $3.81 |
| 50 Day Moving Average (SMA50) | $3.87 |
| 100 Day Moving Average (SMA100) | $3.92 |
| 200 Day Moving Average (SMA200) | $3.27 |
SAB Biotherapeutics Statistics
| Average Volume (30 Days) | 594.8K |
|---|---|
| P/E Ratio (Current) | -19.28 |
| EPS (Current) | -$0.18 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$45.71M |
| Cash Ratio | 0.98 |
| Current Ratio | 9.46 |
| Quick Ratio | 9.46 |
| Debt to Equity | 0.02 |
| Enterprise Value | $236.63M |
| EV to EBITDA | -5.16 |
| EV to Sales | — |
| Price to Book | 1.61 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.07% |
| Return on Equity | -0.08% |
SAB Biotherapeutics Stock Splits
There has been 1 stock split for SAB Biotherapeutics (SABS). The reverse stock split occured on January 5, 2024 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 5, 2024 | Reverse | 10:1 |
SAB Biotherapeutics Dividends
There have been no dividends for SAB Biotherapeutics (SABS).